The success of highly active antiretroviral therapy (HAART) has determined a dramatic
decline in AIDS-and immunodeficiency-related causes of death in the HIV-infected …

Highly active antiretroviral therapy (HAART) has increased life expectancy among HIV-
infected individuals, and by 2015, at least half of all HIV-infected individuals will be over 50 …

Objective: To compare the prevalence of metabolic syndrome (MS) in HIV-positive patients
with that from a sample of a general Italian population. Design: Cross-sectional study …

As HAART becomes more accessible in sub-Saharan Africa, metabolic syndromes, body fat
redistribution (BFR), and cardiovascular disease may become more prevalent. We …

Background Renovascular hypertension (RVH) impairs cardiac structure and left ventricular
(LV) function, but whether mitochondrial injury is implicated in RVH‐induced myocardial …

HIV-infected patients on highly active antiretroviral therapy (HAART) have increased
prevalence of a number of chronic metabolic disorders of multifactorial but unclear etiology …

Objective HIV-infected patients had a higher prevalence of insulin resistance (IR) and risk of
diabetes mellitus (DM) than that observed in healthy controls, but there are no data about …

This systematic review and meta-analysis tries to determine whether there is an association
between the use of protease inhibitors (PIs) and the incidence of diabetes mellitus (DM) …

HIV-associated morbidity and mortality have declined significantly since the introduction of
highly active antiretroviral therapy (HAART). These developments have allowed an …

A better understanding of the propensity of individual HIV protease inhibitors to produce
insulin resistance will allow the tailoring of individual treatment plans based upon overall …